Clinical Trial Update: Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluated topical 0.1% bromfenac sodium to inhibit prostaglandin E2 during cataract surgery, aiming to reduce inflammation related to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Bromfenac sodium ophthalmic solution (bromfenac sodium)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Cataract | NA | Status: COMPLETED